Scandinavian Journal of Rheumatology

Glucocorticoid receptor variants may predispose to rheumatoid arthritis susceptibility
pp. 1-5(5)
Authors: Chatzikyriakidou, A.; Georgiou, I.; Voulgari, P. V.; Georgiadis, A. N.; Argyriou, E. S.; Drosos, A. A.

Sustained improvement of vascular endothelial function during anti-TNFα treatment in rheumatoid arthritis patients
pp. 6-10(5)
Authors: Sidiropoulos, P. I.; Siakka, P.; Pagonidis, K.; Raptopoulou, A.; Kritikos, H.; Tsetis, D.; Boumpas, D. T.

Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis
pp. 11-14(4)
Authors: Lee, S-S.; Park, Y-W.; Park, J. J.; Kang, Y. M.; Nam, E. J.; Kim, S. I.; Lee, J. H.; Yoo, W-H.; Lee, S-I.

Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis
pp. 15-22(8)
Authors: Syngle, A.; Vohra, K.; Kaur, L.; Sharma, S.

Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment
pp. 23-27(5)
Authors: Shirinsky, I. V.; Zheltova, O. I.; Solovyova, N. Y.; Kozlov, V. A.; Shirinsky, V. S.

The efficacy of rehabilitation for patients with rheumatoid arthritis: comparison between a 4-week rehabilitation programme in a warm and a cold climate
pp. 28-37(10)
Authors: Staalesen Strumse, Y. A.; Nordvåg, B-Y.; Stanghelle, J. K.; Røisland, M.; Winther, A.; Pajunen, P-A.; Garen, T.; Flatø, B.

Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity
pp. 38-45(8)
Authors: Kuryliszyn-Moskal, A.; Ciolkiewicz, M.; Klimiuk, P. A.; Sierakowski, S.

IgA rheumatoid factor in primary Sjogren's syndrome
pp. 46-49(4)
Authors: Peen, E.; Mellbye, O. J.; Haga, H-J.

Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome
pp. 50-57(8)
Authors: Fauchais, A. L.; Boumediene, A.; Lalloue, F.; Gondran, G.; Loustaud-Ratti, V.; Vidal, E.; Jauberteau, M. O.

Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study
pp. 58-62(5)
Authors: Lopez-Gonzalez, R.; Loza, E.; Jover, J. A.; Benitez Del Castillo, J. M.; Mendez, R.; Hernandez-Garcia, C.; Pato, E.

Regional migratory osteoporosis in a patient with ankylosing spondylitis
pp. 63-65(3)
Authors: Straten, V. H. H. P.; Franssen, M. J. A. M.; den Broeder, A. A.; Obradov, M.; van den Hoogen, F. H. J.

Antibodies against mutated citrullinated vimentin fail to predict anti-TNFα treatment response in rheumatoid arthritis
pp. 66-67(2)
Authors: Dejaco, C.; Duftner, C.; Klotz, W.; Schirmer, M.; Herold, M.

Retroperitoneal fibrosis associated with psoriasis: a case series
pp. 68-69(2)
Authors: Famularo, G.; Palmisano, A.; Afeltra, A.; Buzzulini, F.; Versari, A.; Minisola, G.; Vaglio, A.

Potential role of macrophage migration inhibitory factor in adult-onset Still's disease
pp. 69-71(3)
Authors: Becker, H.; Gaubitz, M.; Domschke, W.; Willeke, P.

A patient with periodic fever syndrome: a 20-year delay in diagnosis
pp. 71-73(3)
Authors: Ben-Chetrit, E.; Touitou, I.

Lupus anticoagulant and IgM anti-phospholipid antibodies in Korean children with Henoch-Schonlein purpura
pp. 73-74(2)
Authors: Shin, J. I.; Lee, J. S.; Kim, H. S.

Authors' Reply
pp. 74-75(2)
Authors: Salhan, M.; Ahluwalia, J.; Singh, S.; Minz, R. W.

Prevalence of spondyloarthropathy in Lithuania: comment on the article by Adomaviciute et al
pp. 75-76(2)
Author: Akkoc, N.

Authors' Reply
pp. 76-76(1)
Authors: Adomaviciute, D.; Pileckyte, M.; Baranauskaite, A.; Morvan, J.; Dadoniene, J.; Guillemin, F.

ERRATUM
pp. 76-76(1)

Acronyms in rheumatology
pp. 77-78(2)